30
Participants
Start Date
May 1, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Regorafenib and Sintilimab in combination with electroacupuncture
Regorafenib, take for 2 weeks and stop for 1 week; Sintilimab, intravenous, every 3 weeks; Electroacupuncture was performed 1 day before, on the day of, and on the 2nd day after each cycle of Sintilimab administration, and patients completed 3 treatments in week 1, followed by 1 treatment per week for 2 weeks, with 5 treatments per dosing cycle.
RECRUITING
The First People's Hospital of Changzhou, Changzhou
The First People's Hospital of Changzhou
OTHER